BioCentury
ARTICLE | Company News

Kleo, Peptidream partner to discover and develop immunotherapeutics

August 4, 2017 7:51 PM UTC

PeptiDream Inc. (Tokyo:4587) and Kleo Pharmaceuticals Inc. (New Haven, Conn.) partnered to develop immunotherapeutics.

Peptidream will use its Peptide Discovery Platform System to identify and optimize macrocyclic/constrained peptides against cancer targets selected by Kleo...